FridaySep 29, 2017 1:32 pm

AppSwarm, Inc. (SWRM) Aims to Increase Share of the Global Apps and Games Market

AppSwarm helps build, market and sell applications through mergers and acquisitions, joint ventures, partnerships and various other agreements The company is aiming for $6-7 million in revenue by FY 2018, tapping into the nearly $100 billion global games market The app market hit $1.3 trillion in 2016, and AppSwarm’s agreements with major app stores can help developers get to market sooner In 2016, the global games market generated nearly $100 billion in revenue. AppSwarm, Inc. (OTC: SWRM) has built a business model that enables it to work with application developers and entrepreneurs who are great at creating ideas, but need…

Continue Reading

FridaySep 29, 2017 1:14 pm

Bowser Small Cap Stocks Grew 2.6% for Week Ended September 22, Outperforming Major Indices

Leading the way was InfuSystem Holdings (NYSE MKT: INFU), which grew 23% Russell 2000 Index increased 1.3%, faster than other major indices Second week in a row Bowser Stocks surged higher Bowser small cap stocks grew 2.6% for the week ended September 22, outperforming major indices, according to The Bowser Report Weekly. InfuSystem Holdings (NYSE MKT: INFU) led the way, growing 23% for the week. Ironically, INFU was the single biggest loser the prior week, with The Bowser Report Weekly attributing that selloff to an increase in volatility. The company provides infusion pumps and related services to medical facilities. It…

Continue Reading

FridaySep 29, 2017 12:52 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Tech Discussed at “Cannabis in the Capital Markets” Event

Clinical studies of TurboCBD™ a topic of discussion at Canadian Securities Exchange-sponsored “Cannabis in the Capital Markets” event Patents cover variety of lipophilic bio-actives, including cannabinoids, nicotine and vitamins Growing portfolio of intellectual property includes 19 patents filed across 44 countries Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), through its proprietary technology for delivering bioactive compounds in lipid formulations, offers licensed partners the ability to include cannabidiol (CBD) in a variety of ingestible products appropriate for medical patients and recreational users alike. In a new report, Grand View Research, Inc., states that the global market for medical cannabis alone is…

Continue Reading

FridaySep 29, 2017 11:50 am

Luxury Utah Home for Sale Now for a Mere $2.9 Million in Bitcoin

Bitcoin, the digital currency at the center of some trade volatility after the Chinese government issued its clamp down order on the cryptocurrency, is surviving nicely, as prices rose above the $4,100-mark on Thursday. Believers in the virtual currency say that, in spite of several indications that government regulations are going to be part of its future, there are plenty of opportunities to use bitcoin now to purchase tangible assets. Case in point – if you happen to have $2.9 million in bitcoin lying around in your virtual wallet, you could use it to buy a luxury, 5,000-square-foot, seven bedroom,…

Continue Reading

ThursdaySep 28, 2017 3:31 pm

Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) and Canopy Growth (TSX: WEED) (OTC: TWMJF) Sign Definitive Licensing Agreement

Canopy Growth would license and exclusively sell certain Skinvisible Pharmaceutical topical products in Canada while having first rights to market those products in all countries except China and the U.S. Skinvisible to develop Invisicare® technology hemp-based products to be sold under license by Canopy Hemp Corporation in Canada Skinvisible’s Invisicare® technology cannabis-based topical products in the future, if and when THC- and CBD-infused products are legalized in Canada, are also in the agreement Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) and Canopy Growth Corporation (TSX: WEED) (OTC: TWMJF) have announced a definitive agreement for Canopy to license and have exclusive marketing rights…

Continue Reading

ThursdaySep 28, 2017 3:03 pm

ChineseInvestors.com, Inc. (CIIX) Again Names Paul Dickman as CFO, Pursues Exploding $7.2 Billion Legal Cannabis Market

CIIX is pursuing the $7.2 billion legal cannabis market with hemp-based cannabidiol (CBD) products; CIIX showed a 76% year-over-year operating revenues gain in FY2017 Dickman previously served as CFO from 2010-2016; Warren Wang, CIIX’s CEO, said Dickman will “build an infrastructure that supports long-term growth” CIIX has plans to launch a hemp-based line of skin care products in China by year-end 2017 and is already marketing a line of hemp-infused cannabidiol products, “OptHemp,” through its U.S. subsidiary ChineseInvestors.com, Inc. (OTCQB: CIIX) announced in an 8K SEC filing (http://nnw.fm/UA4wB) that Paul Dickman has returned as its chief financial officer, effective September…

Continue Reading

ThursdaySep 28, 2017 2:04 pm

Global Payout, Inc. (GOHE) CEO Discusses Innovative FINTECH Company’s Past, Present and Future

Innovative Global Reserve Platform enables seamless international payments “Banking in a box” Global Reserve Platform provides full front-to-back office processing for banks Solutions serve the global logistics industry, high-risk sectors and more In a recent interview (http://nnw.fm/no3tA) with NetworkNewsWire, Global Payout, Inc. (OTC: GOHE) CEO James Hancock detailed where the innovative payment solutions company has been, where it is now, and where it plans to be in the future. Global Payout is a frontrunner in the FINTECH revolution (http://nnw.fm/3HvjQ), offering versatile and innovative solutions for domestic and international organizations distributing money on a global scale. The company’s solutions include a…

Continue Reading

ThursdaySep 28, 2017 1:25 pm

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Boasts Oil Sands Technology that Could Make Tailings Ponds Passé

Versatile extraction process applicable to both water-wet and oil-wet sands Green technology will save wildlife Closed loop technology uses less water than traditional open loop processes Tailings ponds, despite an innocuous name that makes them sound like an amusement park feature, are anything but amusing. They are as potentially treacherous as serpents hidden in the grass and remain so only because news reporting on their alarming threat has been scant. Containing mammoth quantities of residual toxic sludge, tailings ponds scar the landscapes already disturbed by the oil-sands industry. As if to highlight their destruction, many in Alberta, the hub of…

Continue Reading

ThursdaySep 28, 2017 9:00 am

Cannabis Companies Demonstrate the Diverse Nature of the Global Marijuana Market

NetworkNewsWire Editorial Coverage: The cannabidiol market is large and diverse; just a few years ago, it was rather small but by 2015, consumer sales had reached $202 million, according to the CBD Report published by The Hemp Business Journal. Cannabidiol sales are expected to grow to over $2 billion by 2020. The dollar amounts and projections may seem impressive, but they don’t tell the full story, as market demand is being fueled by an increasing number of applications. Medicinal marijuana is used to treat pain and inflammation, nausea, anxiety and diseases such as epilepsy and glaucoma. The medical community has…

Continue Reading

ThursdaySep 28, 2017 9:00 am

Cannabinoid Biosynthesis Poised as Potential Game-Changer in Drug Development

NetworkNewsWire Editorial Coverage: As the marijuana market continues its widespread growth, researchers remain merely at the threshold of exploring the manifold potential medical applications of cannabis. At present, more than 90 individual cannabinoid compounds have been discovered within the cannabis plant—each one potentially possessing crucial disease-fighting properties either on its own or combined with other compounds. Historically, however, it has been incredibly difficult to extract most of these compounds from the marijuana plant in adequate quantities and purities to be tested pharmaceutically. Overcoming this stumbling block in medical cannabis advancement, Vancouver-based biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF)…

Continue Reading

Contact us: 212.418.1217